Aimmune Therapeutics Provides Update on Ongoing AR101 Phase 3 Program for Peanut Allergy Based on FDA Feedback by Carolyn Helms | Feb 16, 2017 | Portfolio News
Longitude Capital Promotes Josh Richardson, M.D. To Managing Director by Carolyn Helms | Feb 16, 2017 | Longitude Capital News
Tricida Announces Hiring of Wilhelm Stahl as Chief Technology Officer and Senior Vice President by Carolyn Helms | Feb 15, 2017 | Portfolio News15
Practice Fusion Launches EHR-integrated Post-Marketing Active Safety Surveillance Program by Carolyn Helms | Feb 14, 2017 | Portfolio News
